{
    "2021-03-03": [
        [
            {
                "time": "",
                "original_text": "长春高新现2笔大宗交易 ，共成交678.26万元",
                "features": {
                    "keywords": [
                        "长春高新",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新今日大宗交易成交0.50万股，成交价436.9元溢价0.0%",
                "features": {
                    "keywords": [
                        "长春高新",
                        "大宗交易",
                        "成交量",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股异动|长春高新(000661.SZ)涨超4%百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
                "features": {
                    "keywords": [
                        "长春高新",
                        "百克生物",
                        "鼻喷流感疫苗",
                        "临床试验",
                        "上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块复苏，长春高新、智飞生物、西藏药业、康希诺领涨",
                "features": {
                    "keywords": [
                        "长春高新",
                        "疫苗板块",
                        "复苏",
                        "领涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新(000661.SZ)：百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
                "features": {
                    "keywords": [
                        "长春高新",
                        "百克生物",
                        "鼻喷流感疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新：控股子公司鼻喷流感减毒活疫苗获批药物临床试验",
                "features": {
                    "keywords": [
                        "长春高新",
                        "控股子公司",
                        "鼻喷流感疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "午间公告：长春高新子公司、贝达药业获批开展药物临床试验",
                "features": {
                    "keywords": [
                        "长春高新",
                        "子公司",
                        "贝达药业",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}